Search
Search Results
##search.searchResults.foundPlural##
-
AGING WITH THALASSEMIA AND SICKLE CELL DISEASE: A GERONTOLOGICAL MODEL OF ACCELERATED MULTIMORBIDITY AND FUNCTION-CENTERED CARE BEYOND MIDLIFE Thalassemia and Sickle Cell Diseases: Effect of Aging
439PDF: 430Suppl. Files: 60HTML: 32 -
FUNGAL INFECTIONS OF THE EAR IN IMMUNOCOMPROMISED HOST: A REVIEW
3733PDF: 1419HTML: 3805Letter to Editor: 197 -
-
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
8136PDF: 4316HTML: 7519 -
HEMATOPOIETIC STEM CELL TRANSPLANTATION IN SEVERE PEDIATRIC SICKLE CELL DISEASE: OUTCOME AND LONG-TERM COMPLICATIONS, SAUDI EXPERIENCE AT KING FAISAL SPECIALIST HOSPITAL, RIYADH, SAUDI ARABIA HCT in in Severe Pediatric Sickle Cell Disease
1316PDF: 966HTML: 471 -
Guest Editor: G. Castaman GENE THERAPY FOR HEMOPHILIA: FACTS AND QUANDARIES IN THE 21ST CENTURY GENE THERAPY FOR HEMOPHILIA
2151PDF: 1937HTML: 356 -
AUTOIMMUNE CYTOPENIAS IN CHRONIC LYMPHOCYTIC LEUKEMIA, FACTS AND MYTHS
2240PDF: 1220HTML: 3884 -
Successful treatment with eltrombopag in avoiding splenectomy for patients with chronic refractory immune thrombocytopenia
1470PDF: 855HTML: 1080Untitled: 192 -
-
CURRENT ISSUES AND OPTIONS FOR HORMONAL CONTRACEPTION IN ADOLESCENTS AND YOUNG ADULT WOMEN WITH SICKLE CELL DISEASE: AN UPDATE FOR HEALTH CARE PROFESSIONALS Hormonal Contraception in Adolescents and Young Adult Women With Sickle Cell Disease
2245PDF: 1447HTML: 780 -
TREATMENT OF CANCER IN THE OLDER AGED PERSON
1220PDF: 853HTML: 3368 -
THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA The history and roles of deferiprone
2468PDF: 1613HTML: 664 -
ON THE VERSATILITY OF VON WILLEBRAND FACTOR
2870PDF: 1157HTML: 11229 -
-
-
END-OF-LIFE CARE IN SICKLE CELL DISEASE AND TRASFUSION DEPENDEND-β-THALASSEMIA: CLINICAL, PSYCHOLOGICAL, AND ETHICAL CONSIDERATION Challenges in Supportive Care, Equity, and Compassion at End of Life
1116PDF: 786Html: 168 -
HEMATOPOIETIC STEM CELL TRNSPLANTATION IN THALASSEMIA AND RELATED DISORDERS
1480PDF: 495HTML: 3978 -
MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT
868PDF: 490HTML: 1310 -
HIGHLIGHTS ON THE CONTRIBUTION OF GUT MICROBIOTA TO IMMUNE-MEDIATED DISEASES IN CHILDHOOD Gut microbiota in childhood immune-mediated diseases
1100PDF: 757HTML: 122 -
PROPHYLAXIS OF MALARIA
3061PDF: 1055HTML: 17858Figures SChwartz: 177 -
HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT
1003PDF: 542HTML: 731 -
MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS
835PDF: 547HTML: 4026 -
THALASSEMIA AND VENOUS THROMBOEMBOLISM
2990PDF: 1047HTML: 4608 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4872PDF: 1831HTML: 2730Untitled: 235 -
HIV INFECTION, ANTIRETROVIRAL THERAPY AND CARDIOVASCULAR RISK
1917PDF: 810HTML: 3613 -
-
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3427PDF: 1503HTML: 4017 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7743PDF: 2456HTML: 1745Table 1.: 227Table 2.: 239Table 3.: 222Table 4.: 216 -
EFFECT OF FRESH VERSUS CRYOPRESERVED GRAFTS ON FEBRILE NEUTROPENIA AND INFECTIONS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION: FACTORS DETERMINING MORTALITY. Fresh vs Frozen Grafts: Infection and Outcome
947PDF: 668HTML: 166







